Berberine: Clinical Evidence & Substantiation Summary

Clinical Trials
47
Strongest Evidence
Blood Sugar Support
Typical Dosage
500–1,500 mg/day (divided doses)
Common Forms
Berberine HCl

What Is Berberine?

Berberine is an alkaloid found in several plants including goldenseal, barberry, and Oregon grape. It has gained significant attention for its effects on blood sugar metabolism, lipid profiles, and gut health, with clinical evidence rivalling some pharmaceutical interventions.

Mechanism of action: Berberine activates AMP-activated protein kinase (AMPK), a master metabolic regulator. It improves insulin sensitivity, enhances glucose uptake in muscle cells, inhibits hepatic gluconeogenesis, and modulates gut microbiota composition. It also inhibits PCSK9, contributing to LDL cholesterol reduction.

Clinical Evidence Summary

Below are 5 key clinical studies on Berberine. Nutra Comp analyses 47+ studies in its full clinical evidence report.

Meta-analysis2020PMID: 32268543

Berberine for glucose and lipid metabolism: a meta-analysis

Population: 28 RCTs, 2,569 participants

Key finding: Berberine significantly reduced fasting blood glucose (WMD: -7.68 mg/dL, p<0.001) and total cholesterol (WMD: -18.9 mg/dL, p<0.001).

Systematic review and meta-analysis2018PMID: 30466985

Efficacy and safety of berberine for type 2 diabetes management

Population: 14 RCTs

Key finding: Berberine reduced HbA1c by 0.65% (p<0.001) and was comparable to metformin in several head-to-head trials.

Berberine modulates gut microbiota in metabolic disorders

Population: 78 participants

Key finding: Berberine supplementation significantly altered gut microbiota composition, increasing short-chain fatty acid-producing bacteria (p<0.01).

Systematic review2018PMID: 29307925

Berberine and cardiovascular risk factors: a systematic review

Population: 21 RCTs

Key finding: Berberine significantly reduced LDL cholesterol (WMD: -20.2 mg/dL, p<0.001) and triglycerides (WMD: -35.9 mg/dL, p<0.001).

Meta-analysis2021PMID: 33260899

Anti-inflammatory effects of berberine supplementation

Population: 10 RCTs

Key finding: Berberine significantly reduced CRP levels (WMD: -1.07 mg/L, p=0.003) in metabolic syndrome populations.

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

9
Supports healthy blood sugar levels already within the normal range
Category: Blood Sugar · Confidence: 9/10
8
Supports healthy cholesterol levels already within the normal range
Category: Cardiovascular · Confidence: 8/10
7
Supports a healthy gut microbiome
Category: Gut Health · Confidence: 7/10

Get the full substantiation report for Berberine

Includes all 47+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Alpha-Lipoic Acid (ALA)
52 studies · Blood Sugar Support
Chromium
64 studies · Blood Sugar Management

Key Terms

SubstantiationRandomised Controlled Trial (RCT)Clinically Effective Dose

Frequently Asked Questions

Is berberine FDA approved?

Berberine is sold as a dietary supplement and does not require FDA approval. It is not an FDA-approved drug, though some clinical trials have compared it favourably to metformin for blood sugar management.

What are the most studied benefits of berberine?

The strongest evidence supports berberine for blood sugar management (reducing fasting glucose and HbA1c), lipid metabolism (reducing LDL and triglycerides), and gut microbiome modulation.

What dosage of berberine is used in clinical studies?

Most studies use 500 mg two to three times daily (1,000–1,500 mg/day total), taken with meals. Divided dosing is recommended due to berberine's short half-life.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist